Current awareness of piperazines: pharmacology and toxicology (Q37899848)

25 August 2017

1 reference

title

Current awareness of piperazines: pharmacology and toxicology (English)

1 reference

25 August 2017

1 reference

Simon Elliott

1 reference

25 August 2017

language of work or name

1 reference

11 July 2011

1 reference

full work available at URL

25 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fdta.307

1 reference

http://onlinelibrary.wiley.com/wol1/doi/10.1002/dta.307/fullpdf

6 December 2024

1 reference

Drug Testing and Analysis

6 December 2024

published in

1 reference

25 August 2017

1 reference

25 August 2017

issue

7-8

1 reference

25 August 2017

page(s)

430-438

1 reference

Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market

25 August 2017

cites work

1 reference

Investigation of the first deaths in the United Kingdom involving the detection and quantitation of the piperazines BZP and 3-TFMPP.

21 January 2018

1 reference

1-m-Chlorophenylpiperazine is an active metabolite common to the psychotropic drugs trazodone, etoperidone and mepiprazole

21 January 2018

1 reference

A2 (N-benzylpiperazine) a new drug of abuse in Sweden

21 January 2018

1 reference

Legal piperazine-containing party pills--a new trend in substance misuse

21 January 2018

1 reference

A comparison of the effects of 1-benzylpiperazine and dexamphetamine on human performance tests.

21 January 2018

1 reference

Comparison of the effects of dexamphetamine and 1-benzylpiperazine in former addicts

21 January 2018

1 reference

Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain

21 January 2018

1 reference

N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').

21 January 2018

1 reference

Effects of benzylpiperazine derivatives on the neurotoxicity of 3,4-methylenedioxymethamphetamine in rat brain

21 January 2018

1 reference

Central serotonergic effects of m-chlorophenylpiperazine (mCPP) among normal control adolescents

21 January 2018

1 reference

1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain.

21 January 2018

1 reference

Treatment of adolescent rats with 1-benzylpiperazine: a preliminary study of subsequent behavioral effects

21 January 2018

1 reference

Rewarding properties of 1-benzylpiperazine, a new drug of abuse, in rats

21 January 2018

1 reference

Chronic benzylpiperazine (BZP) exposure produces behavioral sensitization and cross-sensitization to methamphetamine (MA).

21 January 2018

1 reference

MDMA-like behavioral effects of N-substituted piperazines in the mouse

21 January 2018

1 reference

Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys

21 January 2018

1 reference

N-benzylpiperazine has characteristics of a drug of abuse.

21 January 2018

1 reference

Determining the subjective and physiological effects of BZP combined with TFMPP in human males.

21 January 2018

1 reference

Determining the subjective and physiological effects of BZP on human females

21 January 2018

1 reference

Randomised double-blind, placebo-controlled trial of the effects of the 'party pills' BZP/TFMPP alone and in combination with alcohol.

21 January 2018

1 reference

m-Chlorophenylpiperazine as a probe of serotonin function

21 January 2018

1 reference

The subjective effects of MDMA and mCPP in moderate MDMA users

21 January 2018

1 reference

Studies on the metabolism and toxicological detection of the new designer drug N-benzylpiperazine in urine using gas chromatography-mass spectrometry.

21 January 2018

1 reference

Chemistry, Pharmacology, Toxicology, and Hepatic Metabolism of Designer Drugs of the Amphetamine (Ecstasy), Piperazine, and Pyrrolidinophenone Types

21 January 2018

1 reference

Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (

21 January 2018

1 reference

New designer drug 1-(3-trifluoromethylphenyl) piperazine (TFMPP): gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry studies on its phase I and II metabolism and on its toxicological detection in rat urine.

21 January 2018

1 reference

Pharmacokinetics of 'party pill' drug N-benzylpiperazine (BZP) in healthy human participants

21 January 2018

1 reference

Validation of an LC-MS method for the detection and quantification of BZP and TFMPP and their hydroxylated metabolites in human plasma and its application to the pharmacokinetic study of TFMPP in humans

21 January 2018

1 reference

New designer drug 1-(3,4-methylenedioxybenzyl) piperazine (MDBP): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry.

21 January 2018

1 reference

Studies on the metabolism and the toxicological analysis of the nootropic drug fipexide in rat urine using gas chromatography-mass spectrometry

21 January 2018

1 reference

In vivo metabolism of the new designer drug 1-(4-methoxyphenyl)piperazine (MeOPP) in rat and identification of the human cytochrome P450 enzymes responsible for the major metabolic step

21 January 2018

1 reference

Toxicological detection of the new designer drug 1-(4-methoxyphenyl)piperazine and its metabolites in urine and differentiation from an intake of structurally related medicaments using gas chromatography-mass spectrometry.

21 January 2018

1 reference

Piperazine-derived designer drug 1-(3-chlorophenyl)piperazine (mCPP): GC-MS studies on its metabolism and its toxicological detection in rat urine including analytical differentiation from its precursor drugs trazodone and nefazodone

21 January 2018

1 reference

Human CYP2D6 and metabolism of m-chlorophenylpiperazine

21 January 2018

1 reference

In vitro identification of metabolic pathways and cytochrome P450 enzymes involved in the metabolism of etoperidone

21 January 2018

1 reference

Bioactivation of the nontricyclic antidepressant nefazodone to a reactive quinone-imine species in human liver microsomes and recombinant cytochrome P450 3A4.

21 January 2018

1 reference

Pharmacokinetics of m-chlorophenylpiperazine after intravenous and oral administration in healthy male volunteers: implication for the pharmacodynamic profile

21 January 2018

1 reference

Pharmacokinetic and pharmacodynamic profile of oral and intravenous meta-chlorophenylpiperazine in healthy volunteers

21 January 2018

1 reference

LC-MS/MS screening method for designer amphetamines, tryptamines, and piperazines in serum

21 January 2018

1 reference

Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry

21 January 2018

1 reference

Application of direct urine LC-MS-MS analysis for screening of novel substances in drug abusers

21 January 2018

1 reference

Acute chlorophenylpiperazine overdose: a case report and review of the literature.

21 January 2018

1 reference

Fipexide-induced fulminant hepatitis. Report of three cases with emergency liver transplantation.

21 January 2018

1 reference

Multiorgan failure from 1-benzylpiperazine ingestion--legal high or lethal high?

21 January 2018

1 reference

Toxicity from the recreational use of 1-benzylpiperazine

21 January 2018

1 reference

Dissociative and sympathomimetic toxicity associated with recreational use of 1-(3-trifluoromethylphenyl) piperazine (TFMPP) and 1-benzylpiperzine (BZP).

21 January 2018

1 reference

Fatal brain edema after ingestion of ecstasy and benzylpiperazine

21 January 2018

1 reference

21 January 2018

Seizures in a night club

1 reference

7 January 2021

Circling behaviour induced by dopamine releasers and/or uptake inhibitors during degeneration of the nigrostriatal pathway

1 reference

7 January 2021

Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder

1 reference

7 January 2021

Collapse, reported seizure--and an unexpected pill

1 reference

7 January 2021

Effects of the pyrones, maltol and ethyl maltol, on iron absorption from the rat small intestine

1 reference

Metabolic interactions with piperazine-based 'party pill' drugs

6 December 2024

1 reference

6 December 2024

Identifiers

DOI

10.1002/DTA.307

1 reference

25 August 2017

1 reference